October 18 (SeeNews) - Serbia's government is due to begin negotiations with a consortium of Britain's Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm for the sale of 25% of drug maker Galenika on October 24, according to Serbian media repors.